Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


J Am Soc Nephrol 18: 13-, 2007
© 2007 American Society of Nephrology
doi: 10.1681/ASN.2007060701

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

This Month's Highlights


    BASIC RESEARCH
 Top
 BASIC RESEARCH
 CLINICAL EPIDEMIOLOGY
 CLINICAL RESEARCH
 
Hybrid Glomeruli Provide Clues About Glomerulogenesis

Figure 1
Laminins are integral components of glomerular basement membranes. Abrahamson and colleagues explored the role of laminins in glomerulogenesis by studying hybrid glomeruli comprising podocytes from laminin {alpha}5 knockout mice and endothelial cells from wild-type mice. By localizing the different isoforms of laminin expressed by podocytes and endothelial cells in these hybrids, the authors demonstrate that both cell types contribute significantly to the formation of the glomerular basement membrane, that the laminins remain attached to their cell of origin, and that proper development of podocyte foot processes requires normal composition of the underlying basement membranes. See Abrahamson et al., pages 2285–2293.

Angiotensin II Blockade Stabilizes Atherosclerotic Plaques

Figure 2
Atherosclerosis ravages patients with kidney disease. Blockade of the renin-angiotensin system reduces the associated morbidity and mortality, but the mechanisms underlying these effects are incompletely understood. Using apolipoprotein E–deficient mice with established atherosclerosis, Suganuma and colleagues found that treatment with the renin-angiotensin system inhibitor losartan not only slows progression of atherosclerotic plaques but also alters their composition. Losartan increases the relative amount of collagen in plaques and reduces the destruction of elastin in the arterial wall. Therefore, angiotensin II blockade may reduce the risk of plaque rupture in addition to reducing the atherosclerotic burden. See Suganuma et al., pages 2311–2319.

Anti-PR3 Antibodies Stimulate the Expression of Their Own Antigen

Figure 3
ANCA (anti-neutrophil cytoplasmic antibodies) directed against neutrophil proteinase 3 (PR3) are found in a subset of vasculitides, but their contribution to the pathogenesis of disease is not well understood. Brachemi and colleagues demonstrate that anti-PR3 interacts with membrane-bound antigen (mPR3) only after mPR3-expressing neutrophils have been activated by inflammatory cytokines and have adhered to vascular endothelial cells. Moreover, this antibody–neutrophil interaction stimulates additional translocation of PR3 to the cell surface, which may lead to a destructive positive feedback loop in the small vessels where neutrophils are known to wreak havoc in these autoimmune diseases. See Brachemi et al., pages 2330–2339.


    CLINICAL EPIDEMIOLOGY
 Top
 BASIC RESEARCH
 CLINICAL EPIDEMIOLOGY
 CLINICAL RESEARCH
 
Mathematical Equations Assess Hemoglobin Trajectories

Figure 4
The hemoglobin concentration of a patient treated with epoetin often fluctuates around a target value as the drug regimen is adjusted in response to laboratory data. Using patient-level data from a previously published trial, West and colleagues describe a method by which a treatment algorithm can be evaluated for how well it achieves and maintains hemoglobin targets. They modeled individual trajectories of hemoglobin values over time with mathematical functions, and then analyzed these functions to assess how well protocol-driven adjustments in dosage stabilized hemoglobin levels at target. This type of approach may prove useful for the development of treatment protocols in clinical practice or future trials. See West et al., pages 2371–2376.


    CLINICAL RESEARCH
 Top
 BASIC RESEARCH
 CLINICAL EPIDEMIOLOGY
 CLINICAL RESEARCH
 
Nondiabetics May Need to Worry about Fasting Glucose

Figure 5
Diabetic patients on hemodialysis are often chronically inflamed, malnourished, and at increased risk for cardiovascular death. The association of fasting glucose level with these characteristics has not received as much attention among nondiabetic patients on dialysis. Lin-Tan and colleagues prospectively assessed markers of both nutritional status and inflammation in 693 hemodialysis patients in Taiwan. Their analysis suggests that higher fasting glucose levels are associated with reduced serum albumin, increased high-sensitivity C-reactive protein, and increased 1-year mortality, even among nondiabetic patients. Whether interventions targeting glucose metabolism in these patients will affect outcome remains to be determined. See Lin-Tan et al., pages 2385–2391.

Mutations in Complement Pathway Affect HUS Course

Figure 6
Dysregulation of the complement cascade has been implicated in the pathogenesis of atypical hemolytic uremic syndrome (HUS). Sellier-Leclerc and colleagues studied 46 pediatric patients with atypical HUS and found associations between genetic susceptibility traits and clinical course. Half of the children had mutations in Factor H, Factor I, or membrane cofactor protein. Age at onset of symptoms, number of relapses during the first 10 years, and renal survival differed on the basis of which protein was mutated. In addition, triggering events were often identified in mutation carriers, suggesting that these mutations may modify risk rather than cause the syndrome. See Sellier-Leclerc et al., pages 2392–2400.


Related Articles

Functional Data Analysis Applied to a Randomized Controlled Clinical Trial in Hemodialysis Patients Describes the Variability of Patient Responses in the Control of Renal Anemia
Robert M. West, Katie Harris, Mark S. Gilthorpe, Cae Tolman, and Eric J. Will
J. Am. Soc. Nephrol. 2007 18: 2371-2376. [Abstract] [Full Text] [PDF]

Differential Impact of Complement Mutations on Clinical Characteristics in Atypical Hemolytic Uremic Syndrome
Anne-Laure Sellier-Leclerc, Veronique Fremeaux-Bacchi, Marie-Agnès Dragon-Durey, Marie-Alice Macher, Patrick Niaudet, Geneviève Guest, Bernard Boudailliez, François Bouissou, Georges Deschenes, Sophie Gie, Michel Tsimaratos, Michel Fischbach, Denis Morin, Hubert Nivet, Corinne Alberti, Chantal Loirat for the French Society of Pediatric Nephrology
J. Am. Soc. Nephrol. 2007 18: 2392-2400. [Abstract] [Full Text] [PDF]

Angiotensin Inhibition Decreases Progression of Advanced Atherosclerosis and Stabilizes Established Atherosclerotic Plaques
Eisuke Suganuma, Vladimir R. Babaev, Masaru Motojima, Yiqin Zuo, Nobuhiko Ayabe, Agnes B. Fogo, Iekuni Ichikawa, MacRae F. Linton, Sergio Fazio, and Valentina Kon
J. Am. Soc. Nephrol. 2007 18: 2311-2319. [Abstract] [Full Text] [PDF]

Increased Membrane Expression of Proteinase 3 during Neutrophil Adhesion in the Presence of Anti–Proteinase 3 Antibodies
Soumeya Brachemi, Agnès Mambole, Fadi Fakhouri, Luc Mouthon, Loïc Guillevin, Philippe Lesavre, and Lise Halbwachs-Mecarelli
J. Am. Soc. Nephrol. 2007 18: 2330-2339. [Abstract] [Full Text] [PDF]

Fasting Glucose Levels in Predicting 1-Year All-Cause Mortality in Patients Who Do Not Have Diabetes and Are on Maintenance Hemodialysis
Dan-Tzu Lin-Tan, Ja-Liang Lin, Li-Hua Wang, Li-Mei Wang, Lan-Mei Huang, Lily Liu, Jeng-Yi Huang, and Yen-Lin Huang
J. Am. Soc. Nephrol. 2007 18: 2385-2391. [Abstract] [Full Text] [PDF]

Partial Rescue of Glomerular Laminin {alpha}5 Mutations by Wild-Type Endothelia Produce Hybrid Glomeruli
Dale R. Abrahamson, Patricia L. St. John, Kathryn Isom, Barry Robert, and Jeffrey H. Miner
J. Am. Soc. Nephrol. 2007 18: 2285-2293. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
CJASNHome page
V. E. Torres
Role of Vasopressin Antagonists
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1212 - 1218.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP